Recent Price Movement and Benchmark Comparison
Beta Drugs Ltd’s share price has been under pressure over multiple time frames. In the past week, the stock declined by 6.67%, markedly worse than the Sensex’s modest 0.89% fall. Over the last month, the stock’s loss widened to 10.78%, more than double the Sensex’s 4.29% decline. Year-to-date, Beta Drugs Ltd has shed 9.45% of its value, compared to the Sensex’s 4.99% drop. The disparity is even more pronounced over the past year, with the stock plunging 25.57% while the Sensex gained 6.78%. These figures highlight a sustained period of underperformance against the benchmark index.
Technical Indicators and Trading Patterns
On 01-Feb, Beta Drugs Ltd hit a new 52-week low of ₹1,384.90, underscoring the...
Read full news article





